Subcutaneous Trastuzumab (Herceptin) Approved in EUSubcutaneous Trastuzumab (Herceptin) Approved in EU

The subcutaneous administration of the targeted therapy is much quicker than the usual intravenous infusion, and opens up the possibility of patients using it at home. International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news